Research System · Core Technology
Core Questions
AOWEISI’s foundational research is organized around four questions covering cargo and signaling, preparation and delivery, formulation and storage, and process and quality. Together, they connect mechanistic observation with sample assessment and engineering validation. Each question must be examined under defined material conditions, model types, and test methods, with evidence built through repeated records and comparisons.
We study the mRNA, microRNA, bioactive proteins, and lipid structures carried by exosomes, asking how cargo composition, loading methods, and material conditions relate to cellular signaling. This includes measuring cargo types and relative levels, then observing changes in genes, proteins, and functional readouts in defined models. Signal design does not mean assigning a predetermined effect. It means using recorded, comparable experimental conditions to investigate possible links between cargo features and cellular responses.
Between preparation and model assessment, exosomes pass through separation, purification, storage, reconstitution, and delivery. Each step may change the state of the material. We monitor particle size, concentration, morphology, markers, and functional readouts in the model, then compare the effects of temperature, time, containers, media, and handling. The aim is not to claim that function remains unchanged. It is to identify where variation occurs and use that information when selecting formulations and experimental conditions.
Bioactivity stability depends on formulation composition, lyophilization protection, storage temperature, freeze-thaw cycles, reconstitution, and the observation period. Under defined conditions, we compare physicochemical properties, integrity measures, and model readouts, record changes over time and during handling, and assess the suitability of different protection systems. These studies help identify how sensitive a sample is to its environment and which parameters require continued control during preparation, transport, and use.
Standardized preparation involves more than increasing output. Raw materials and carrier conditions, critical process parameters, process records, test methods, and release criteria must also be aligned. We compare particle-size distribution, concentration, purity, markers, and other quality measures across batches, observe how process changes affect the material, and record deviations and their handling. Data from consecutive batches, assessed by consistent methods, provide the basis for judging process reproducibility and planning later optimization and scale-up studies.
Platform technology mechanisms
Our synthetic-biology exosome platform is studied through six connected areas: information cargo, signaling pathways, delivery behavior, microenvironmental markers, formulation stability, and standardized preparation. Each area addresses a different question, but all draw on the same foundation of material characterization, model observation, and quality assessment. This allows mechanistic and engineering work to inform one another as the research develops.
Information cargo and mechanisms
The mRNA, microRNA, bioactive proteins, and lipid structures carried by exosomes form a complex information cargo. We examine cargo composition, relative levels, and batch differences, then study how these features relate to cell-to-cell communication, gene expression, and protein signaling in defined cellular or tissue models. This work looks beyond any single component. It considers the combination of cargo, the state of recipient cells, and the surrounding microenvironment. We distinguish what is detected in the material from what is observed in the model, and then ask whether the evidence supports a mechanistic interpretation rather than treating correlation as established causation.
Pathway regulation and cell fate
Our mechanistic studies examine how pathways such as Wnt/β-catenin, TGF/Smad, NF-kB, and Nrf2 relate to cell renewal, inflammatory signaling, oxidative stress, and barrier status. We consider the model type, material dose, treatment period, and control conditions when observing changes in genes, proteins, and functional readouts. We also compare whether signals move in consistent or opposing directions. A pathway marker helps describe cellular state; it is not a functional conclusion by itself. Possible mechanisms are discussed only when the model, method, and repeated observations support one another.
Delivery systems and distribution behavior
Contact with a cell is only the starting point for delivery assessment. We also need to know under what conditions uptake occurs, where material is distributed after entering a model, how long it remains, and how release changes over time. Depending on the research question, AOWEISI uses cellular, skin, mucosal, or local tissue models together with labeling, quantitative measurements, and comparisons across time points. We distinguish cellular uptake, entry into a defined region, and functional cargo delivery as separate levels of evidence. This gives delivery-system design and later application assessment a clearer basis for interpretation.
Inflammatory signaling, oxidative stress, and barrier status
Inflammatory signaling, oxidative stress, and barrier status are often assessed together in studies of skin, mucosa, and other local microenvironments. Under defined model conditions, material doses, and observation periods, we record changes in markers including NF-kB, TNF-α, IL-6, IL-1β, Nrf2, SOD, HO-1, FLG, and CLDN1. These results are considered alongside cellular state, barrier-related readouts, and control groups. The markers describe changes within a model; they do not by themselves demonstrate anti-inflammatory, antioxidant, or barrier-repair effects in humans and should not be interpreted outside the conditions in which they were measured.
Formulation stability and bioactivity preservation
For a platform technology, formulation and storage conditions determine whether a sample remains suitable for later assessment. Our stability studies examine buffer systems, protective agents, lyophilization, storage temperature, freeze-thaw cycles, transport conditions, and reconstitution methods. At selected time points, we compare particle size, concentration, morphology, integrity, and model readouts. A single measurement is not enough; trends and possible failure conditions matter as well. These records help define storage windows, handling requirements, and retesting points for a particular material, supporting repeatable experiments, sample delivery, and later application studies.
Standardized preparation and scale-up
Alongside mechanistic research, AOWEISI studies carrier preparation, quality consistency, and process scale-up. The work covers raw materials and culture conditions, separation and purification, critical process parameters, in-process controls, batch records, and release assessment. Data from consecutive batches are used to track variation in particle size, concentration, purity, markers, and other quality measures. Scale-up is not a simple repetition of a single experiment. Changes in equipment, volume, and handling may alter the material and must be assessed. Recording deviations, comparing trends, and refining evaluation criteria builds the engineering evidence needed to study reproducibility at a larger scale.
Core research focus
We study how information cargo, key signalling pathways, delivery efficiency, bioactivity retention and manufacturing consistency relate to one another, and how the platform can support research on skin, female mucosa, nasal mucosa and structural matrices.
Public evidence
The published sources below provide background on extracellular-vesicle characterization, reporting and storage stability. The material links provide existing COA, safety and public report records for the corresponding batches. The two evidence types are presented separately: they do not establish full MISEV conformity for AOWEISI materials, nor do batch records constitute human efficacy or clinical conclusions.
Terminology, characterization, separation, functional studies and reporting for extracellular vesicles.
The evolution of MISEV recommendations and the context for transparency and reproducibility in extracellular-vesicle research.
Research background on extracellular-vesicle storage, freeze-thaw handling, preservation stability and bioactivity retention.
Batch records
These links lead to the records currently published on each material page. A COA, safety record or report applies only to the sample, batch, tests and results explicitly documented. Any use in a specific research conclusion requires further review of the report number, model, dose, controls, endpoints and statistical information.
Next Step
Foundational technology research provides the mechanistic, material, and engineering basis for later application assessment. Skin, the female intimate microenvironment, and respiratory mucosa each require different models and evaluation priorities. Explore our applied research to see how these foundational areas inform model design, marker selection, and application-specific assessment.
